Respiratory syncytial virus infection research hub
4 indexed studies · 3 currently recruiting
- authorisedTherapeutic use (Phase IV)
A Pragmatic Randomized Trial to Evaluate the Relative Effectiveness of Abrysvo® Revaccination Versus a Single Primary Dose for Preventing RSV-associated Lower Respiratory Tract Disease in Immunocompromised Adults (DAN-RSV IC REVAX)
This study looks at the RSV vaccine, Abrysvo, in adults with weakened immune systems. Researchers want to find out whether getting a second booster jab gives better protection against serious chest infections and hospital visits than receiving just a single dose.
Denmark - recruitingHuman Pharmacology (Phase I)- Other
A clinical study of MK-3508 in healthy people (MK-3508-006)
This study is looking into a new medicine, MK-3508, for healthy people. It's designed to see how the medicine works in the body and if it's safe. The goal is to help protect against a common chest infection called RSV.
Belgium - recruitingHuman Pharmacology (Phase I)- First administration to humans
A Single Ascending Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of MK-3508 in Healthy Participants
This study is testing a new medicine, MK-3508, for a common cold-like illness called RSV. Researchers want to see if it's safe, how well people tolerate it, and how the body handles the medicine. It's for healthy adult men.
Belgium - recruitingHuman Pharmacology (Phase I)- Other
MK-3508 Multiple Ascending Dose Study in Healthy Participants
This study is looking into a new medicine called MK-3508. It's designed to help fight a common cold-like illness called RSV. We want to see how safe the medicine is at different doses and how the body handles it in healthy adult volunteers.
Belgium